Darnisha Atrice Ruth, SLP | |
4971 Groom Rd, Baker, LA 70714-3145 | |
(225) 775-7051 | |
(225) 774-7244 |
Full Name | Darnisha Atrice Ruth |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 4971 Groom Rd, Baker, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033832860 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 9160 (Louisiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Darnisha Atrice Ruth, SLP 1326 Church St, Zachary, LA 70791-2743 Ph: (225) 654-8208 | Darnisha Atrice Ruth, SLP 4971 Groom Rd, Baker, LA 70714-3145 Ph: (225) 775-7051 |
News Archive
Silence Therapeutics plc announces positive research findings demonstrating the ability of the Company's lead RNA interference (RNAi) drug candidate, Atu027, to prevent the formation of pulmonary metastasis in various animal models of cancer metastasis. Researchers showed that Atu027 inhibited multiple key biological processes that enable and contribute to the dissemination and formation of pulmonary metastases in a murine breast cancer metastasis model.
The Wall Street Journal Health Blog: Consumer groups are already concerned that insurers might lobby HHS Secretary Kathleen Sebelius to weaken the medical-loss ratio rules suggested by the National Association of Insurance Commissioners last week. "Today, consumer representatives sent a letter to HHS Secretary Kathleen Sebelius to urge her not to tinker too much with what the NAIC came up with." The medical-loss ratio rules will determine "how much insurers pay out in health care compared with the total premiums they collect.
Hospitals in Los Angeles vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable. On February 2, www.ConsumerReportsHealth.org will post hospital infection rates for 41 Los Angeles area hospitals, along with other critical patient safety and satisfaction information for consumers.
Results from the VeriStrat analysis of a phase II trial of first line erlotinib in combination with sorafenib in patients with advanced non-small cell lung cancer were presented today at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets in Cancer Therapeutics being held in Berlin, Germany by Egbert Smit, MD, PhD of the VU Medical Center, Amsterdam, The Netherlands.
› Verified 5 days ago
Mrs. Michelle Winfrey Reado, M.ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3802 Myrtle St, Baker, LA 70714 Phone: 225-775-2562 | |
Miss Brittney Dion Raby, M.S. CCC-SLP, L-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7206 Juno Dr, Baker, LA 70714 Phone: 225-341-9141 | |
Iris G. King, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1725 Felton St, Baker, LA 70714 Phone: 225-610-9390 | |
Ms. Andrea Monique Branch, M.ED Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12812 Driftwood Dr, Baker, LA 70714 Phone: 225-775-6535 Fax: 225-324-8709 |